The Palico Private Equity Fund Marketplace
Mission Bay Capital is a private equity general partner firm headquartered in San Francisco, CA, United States.
Chrono Therapeutics, a developer of digital drug therapies, raised $47.6m in a Series B funding round led by Kaiser Permanente Ventures.
Caribou Biosciences, a CA-based developer of CRISPR-Cas technologies for genome engineering, completed a $30m Series B funding round.
ViewPoint Therapeutics, a SF-based biotechnology firm, closed a $4m Series A round co-led by Mission Bay Capital and Lagunita BioSciences.
Read more news concerning Mission Bay Capital
A sampling of Mission Bay Capital portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?